Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-03-04

Clinical Trial Update: BenRalizumab Effect on Airway Remodeling in Severe asTHma [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating benralizumab's effect on airway remodeling in severe asthma with eosinophilic features; recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Benralizumab (benralizumab)

Snippet

Sponsor: Aristotle University Of Thessaloniki | Conditions: Asthma; Eosinophilic, Airway Remodeling | Phase 4 | Status: RECRUITING